drugset / Trial / NCT00865280
Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the treatment of complicated skin and skin structure infections (cSSSI).
Timeline
- Start
- 2009-04-04
- Primary completion
- 2010-04-15
- Completion
- 2010-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linezolid | Other / unclassified | 600 mg | Oral |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | Omadacycline | Small molecule | 300 mg | Intravenous |